Here's what's happening: While most traders are guessing their way through year-end volatility, smart money is positioning for 2025's final opportunities.
The difference? They're reacting. You could be predicting.
Our A.I. forecasted some major trend reversals so far this week. Not after the fact. Before the move happened. That's the edge between watching opportunities pass and actually capturing them.
Ready to see the highest-probability stock and options trades for the days ahead?
While others are guessing, you'll know your next move.
Lennar (LEN) reported earnings of $2.03 per share on revenue of $9.37 billion for the fiscal fourth quarter ended November 2025. The consensus earnings estimate was $2.23 per share on revenue of $9.15 billion. The Earnings Whisper number was $2.18 per share. The company missed expectations by 6.88% while revenue fell 5.82% compared to the same quarter a year ago.
The company said it expects first-quarter homebuilding revenue of $6.205 billion to $7.125 billion. The current consensus estimate is for total revenue $7.84 billion for the quarter ending February 28, 2026.
Lennar Corporation is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-up and active adult homes primarily under the Lennar brand name.
Negative Guidance
Pfizer Sees Earnings Below Estimates
Pfizer, Inc. (PFE) said it continues to expect 2025 earnings of $3.00 to $3.15 per share on revenue of approximately $62.0 billion. The current consensus earnings estimate is $3.17 per share on revenue of $62.80 billion for the year ending December 31, 2025. The company also said it expects 2026 earnings of $2.80 to $3.00 per share on revenue of $59.50 billion to $62.50 billion. The current consensus earnings estimate is $3.08 per share on revenue of $62.43 billion for the year ending December 31, 2026.
Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare.
Duluth Lowers Guidance
Duluth Holdings Inc. (DLTH) said it now expects fiscal 2026 revenue of $555.0 million to $565.0 million. The company's previous guidance was revenue of $570.0 million to $595.0 million, and the current consensus estimate is revenue of $575.5 million for the year ending January 31, 2026.
Duluth Trading is a growing lifestyle brand for the Modern, Self-Reliant American.
Inside, Marc Lichtenfeld - bestselling author of Get Rich with Dividends and world-renowned income expert - is giving away his top five dividend picks.
Duluth (DLTH) reported a loss of $0.23 per share on revenue of $114.87 million for the fiscal third quarter ended October 2025. The consensus estimate was a loss of $0.56 per share on revenue of $118.40 million. The company beat consensus estimates by 58.93% while revenue fell 9.59% compared to the same quarter a year ago.
The company said it now expects fiscal 2026 revenue of $555.0 million to $565.0 million. The company's previous guidance was revenue of $570.0 million to $595.0 million, and the current consensus estimate is revenue of $575.5 million for the year ending January 31, 2026.
Duluth Trading is a growing lifestyle brand for the Modern, Self-Reliant American.
OrganiGram (OGI) reported a loss of $0.20 per share on revenue of $56.91 million for the fiscal fourth quarter ended September 2025. The consensus estimate was a loss of $0.01 per share on revenue of $53.14 million. The company missed consensus estimates by 1,900.00% while revenue grew 73.67% on a year-over-year basis.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.
Micron Technology is Expected to Beat Estimates
Micron Technology (MU) is confirmed to report earnings on Wednesday, December 17, 2025 at approximately 4:00 PM ET. The consensus earnings estimate is $3.89 per share on revenue of $12.54 billion, respresenting 44.0% year-over-year revenue growth, and the Earnings Whisper ® number is $4.00 per share. Investors are 16.8% bullish going into the company's earnings release. Option traders are pricing in a 9.9% move on earnings and the stock has averaged a 8.3% move in recent quarters.
Lennar (LEN) reported earnings of $2.03 per share on revenue of $9.37 billion for the fiscal fourth quarter ended November 2025. The consensus earnings estimate was $2.23 per share on revenue of $9.15 billion. The Earnings Whisper number was $2.18 per share. The company missed expectations by 6.88% while revenue fell 5.82% compared to the same quarter a year ago.
Pfizer, Inc. (
Duluth Holdings Inc. (
OrganiGram (OGI) reported a loss of $0.20 per share on revenue of $56.91 million for the fiscal fourth quarter ended September 2025. The consensus estimate was a loss of $0.01 per share on revenue of $53.14 million. The company missed consensus estimates by 1,900.00% while revenue grew 73.67% on a year-over-year basis.
Micron Technology (MU) is confirmed to report earnings on Wednesday, December 17, 2025 at approximately 4:00 PM ET. The consensus earnings estimate is $3.89 per share on revenue of $12.54 billion, respresenting 44.0% year-over-year revenue growth, and the Earnings Whisper ® number is $4.00 per share. Investors are 16.8% bullish going into the company's earnings release. Option traders are pricing in a 9.9% move on earnings and the stock has averaged a 8.3% move in recent quarters.